Senior insider sale
President and CEO at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$29.66M
890.61K shares
What this filing means
FRANCIS RICHARD D plans to sell 890.61K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $29.66M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/3/2026ACC: 0001973379-26-000075
Officer· President and CEO
Since Mar 2026
890.61K
Shares to sell
$29.66M
Approx. market value
958.55K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
PERFORMANCE SHARE UNIT AWARD VESTING
COMPENSATION
3/3/2023
697.21KPERFORMANCE SHARE UNIT AWARD VESTING
COMPENSATION
3/3/2023
194.10KRESTRICTED SHARE UNIT AWARD VESTING
COMPENSATION
3/3/2023
67.23KTotal acquired958.55K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2023 | PERFORMANCE SHARE UNIT AWARD VESTING COMPENSATION | 697.21K | — |
3/3/2023 | PERFORMANCE SHARE UNIT AWARD VESTING COMPENSATION | 194.10K | — |
3/3/2023 | RESTRICTED SHARE UNIT AWARD VESTING COMPENSATION | 67.23K | — |
| Total | 958.55K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
447.68K
Market value
$15.32M
2/17/2026
Planned — Approximate Date
NYSEPlanned
Units to sell
442.94K
Market value
$14.33M
3/3/2026
Total
Units
890.61K
Value
$29.66M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/17/2026 | 447.68K | $15.32M | — | Completed |
| Planned — Approximate Date | ||||
3/3/2026 | 442.94K | $14.33M | NYSE | Planned |
| Total | 890.61K | $29.66M | ||